Accreditation Statement and Credit Designation

Royal College of Physicians and Surgeons of Canada

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by the Canadian Rheumatology Association. You may claim a maximum of 18 hours (credits are automatically calculated).

American Medical Association (AMA)

Through an agreement between the Royal College of Physicians and Surgeons of Canada and the American Medical Association, physicians may convert Royal College MOC credits to AMA PRA Category 1 Credits. Information on the process to convert Royal College MOC credit to AMA credit can be found at www.ama-assn.org/go/internationalcme 

European Accreditation Council for Continuing Medical Education (UEMS/EACCME)

Live educational activities recognized by the Royal College of Physicians and Surgeons of Canada as Accredited Group Learning Activities (Section 1) are deemed by the European Union of Medical Specialists (UEMS) eligible for ECMEC®.

Credit Breakdown  

Each participant should claim only those hours of credit that he/she actually spent in the educational activity.  

Day	Maximum Credits
21/05/2025	1.5
22/05/2025	6.5
23/05/2025	5.25
24/05/2025	4.75
Total Credits:	18.0

To Receive Your CME/CPD Certificate   

The CME/CPD certificate will be available after completing the online evaluation and credit–claiming procedure. The process takes about 5 minutes. We thank you for your feedback as it is an important part of CME/CPD accreditation and helps improve future educational offerings.

Before 24 June 2025:

1. Access the online system via the following link
2. Complete the anonymous online evaluation
3. Enter your username (conference registration email) and password (Registration ID) during the credit-claiming process
4. Complete the credit claim form and submit

• The CME/CPD certificate will be available for download and retained for your records.
• Please note that web browsers Mozilla Firefox 2.X or higher, or Google Chrome are recommended. Mobile devices are not supported.
• Kindly note that the LUPUS 2025 online evaluation will be active on the last day of the meeting. You will then be able to access it and claim your CME/CPD certificate. 

Educational Objectives

As a result of this educational activity, delegates will be able to:

• Identify and analyze the latest research and advancements in the pathogenesis, diagnosis, and treatment of systemic lupus erythematosus (SLE), including developments in precision medicine and AI-driven approaches.
• Compare and contrast international treatment guidelines (EULAR, ACR, KDIGO) to optimize the management of lupus nephritis (LN) and improve clinical decision-making.
• Assess the impact of emerging therapeutics, including novel biologics, small-molecule inhibitors, and cell-based therapies, in the management of SLE and its complications.
• Interpret new findings in biomarkers, transcriptomics, and proteomics to facilitate earlier and more accurate diagnosis and monitoring of disease progression.
• Examine the influence of comorbidities, mental health disorders, and socioeconomic determinants on lupus outcomes, and integrate holistic, patient-centered management approaches.
• Evaluate the latest strategies for managing pregnancy, fertility, and reproductive health in patients with SLE to enhance maternal and fetal outcomes.
• Recognize and mitigate medication-related toxicities, including hydroxychloroquine (HCQ) retinal, cardiac, and skin toxicity, to ensure safer long-term treatment adherence.
• Explore new methodologies in clinical trial design that promote greater inclusivity, address heterogeneity in SLE, and improve patient recruitment and retention.
• Foster interdisciplinary collaboration among rheumatologists, nephrologists, dermatologists, immunologists, neurologists, and allied healthcare professionals for a multisystem approach to SLE care.
• Enhance professional competency in applying evidence-based treatment strategies to improve patient outcomes and quality of life in individuals with SLE.

The learning objectives for LUPUS 2025 are designed to enhance knowledge, improve clinical practice, and foster interdisciplinary collaboration in the field of systemic lupus erythematosus. The congress will equip participants with cutting-edge insights, evidence-based strategies, and practical tools to advance lupus care worldwide.

• A full list of the Session-Specific Learning Objectives can be found HERE.

Target Audience

The target audience for the 16th International Congress on Systemic Lupus Erythematosus (LUPUS 2025) includes a broad range of healthcare professionals and researchers interested in systemic lupus erythematosus (SLE) and related autoimmune diseases.

• Rheumatologists
• Immunologists

Secondary Target Audience:
The congress aims to provide cutting-edge research and clinical updates on lupus while fostering interdisciplinary collaboration across various specialities to improve patient outcomes.

• Nephrologists
• Dermatologists
• Neurologists
• Hematologists
• Cardiologists
• Obstetricians/Gynecologists
• Primary Care Physicians (PCPs)
• Nurses and Nurse Practitioners
• Pharmacists
• Allied Health Professionals (e.g., physiotherapists, occupational therapists, dietitians, and social workers)

Disclosure and Resolution of Personal Conflicts of Interest

In accordance with CME/CPD accreditation criteria and standards for commercial support to ensure balance, independence, objectivity, and scientific rigor, those in control of the educational content must disclose potential or actual conflicts of interest. Disclosure information is evaluated and conflicts of interest are resolved. Disclosure is made to participants prior to the activity. Participants will be asked on the evaluation to assess the objectivity and independence of the event.

• Disclosure information is available HERE.

Industry Support Disclosure  

This event is supported, in part, by funding from industry. All support is managed in strict accordance with CME/CPD accreditation criteria and standards for commercial support. Appropriate acknowledgement of all supporting organisations is made in the programme guide, on the event website, and with signage during the event.  

• View a list of all industry supporters here.
• View detailed programmes for all Industry Sessions here.

Commitment to the highest standards in CME/CPD

Kenes is committed to being a valuable and knowledgeable partner in the design and delivery of educationally strong, independent, transparent, and effective CME/CPD programs. Kenes is a proud member of the Good CME Practice Group (gCMEp), a member organization contributing to improving health outcomes by:

Championing best practices in CME/CPD

Maintaining and improving standards

Mentoring and educating

Working in collaboration with critical stakeholders

Membership in the Good CME Practice Group illustrates Kenes commitment to high standards and knowledgeable partnership with its clients in the design and delivery of medical events.